⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10463124 | 0.79 | — | — | |
| SCHEMBL1920506 | 0.76 | — | — | |
| SCHEMBL2102789 | 0.76 | — | — | |
| SCHEMBL16382053 | 0.76 | — | — | |
| SCHEMBL11322430 | 0.71 | — | — | |
| SCHEMBL23673185 | 0.70 | — | — | |
| SCHEMBL6854415 | 0.70 | — | — | |
| SCHEMBL2461096 | 0.70 | — | — | |
| SCHEMBL7859917 | 0.69 | — | — | |
| SCHEMBL3584656 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 177 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110015998-A | A kind of synthetic method of 1,5- bis- (to nitro sulfoamido) -1,5- diazo-cyclooc-tane -3,7- diketone | 武汉大学 | 2019-07-16 | — | — | CN | claimed |
| US-20250382305-A1 | COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | PTC THERAPEUTICS INC (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4543444-A1 | COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | PTC Therapeutics, Inc. (US) | 2025-04-30 | — | — | EP | disclosed |
| US-20250051263-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SAIL BIOMEDICINES, INC. | 2025-02-13 | — | — | US | disclosed |
| EP-4436549-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | Sail Biomedicines, Inc. (US) | 2024-10-02 | — | — | EP | disclosed |
| WO-2023250316-A1 | COMPOUNDS FOR TREATING SPINOCEREBELLAR ATAXIA TYPE 3 | PTC THERAPEUTICS, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| US-20230339947-A1 | USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS | Madera Therapeutics, LLC | 2023-10-26 | — | — | US | disclosed |
| US-20230174562-A1 | RADIO-AND CHEMO-PROTECTIVE COMPOUNDS | Tonix Pharmaceuticals, Inc. | 2023-06-08 | — | — | US | disclosed |
| US-20230174562-A1 | RADIO-AND CHEMO-PROTECTIVE COMPOUNDS | Tonix Pharmaceuticals, Inc. | 2023-06-08 | — | — | US | disclosed |
| WO-2023091787-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SENDA BIOSCIENCES, INC. (US) | 2023-05-25 | — | — | WO | disclosed |
| EP-0602306-A1 | Retroviral protease inhibitors | AMERICAN CYANAMID COMPANY (US) | 1994-06-22 | — | — | EP | disclosed |
| CN-1062536-A | Retroviral protease inhibitors from 3-chloro-2-chloromethyl-1-propylene derived | AMERICAN CYANAMID CO (US) | 1992-07-08 | — | — | CN | disclosed |
| EP-0492136-A2 | Retroviral protease inhibitors derived from 3-chloro-2-chloromethyl-1-propene | AMERICAN CYANAMID COMPANY (US) | 1992-07-01 | — | — | EP | disclosed |
| EP-0486948-A2 | Retroviral protease inhibiting compounds | ABBOTT LABORATORIES (US) | 1992-05-27 | — | — | EP | disclosed |
| EP-0480714-A2 | HIV protease inhibitors having symmetrical structure | MERCK & CO. INC. (US) | 1992-04-15 | — | — | EP | disclosed |
| EP-0015412-B1 | UNSATURATED MACROCYCLIC KETONES; THEIR PREPARATION; PREPARATION OF SATURATED MACROCYCLIC KETONES; APPLICATION IN PERFUME AND FLAVOUR COMPOSITIONS OF SOME UNSATURATED MACROCYCLIC KETONES | FIRMENICH SA (CH) | 1983-05-18 | — | — | EP | disclosed |
| EP-0065319-A1 | Process for the preparation of an unsaturated macrocyclic ketone | FIRMENICH SA (CH) | 1982-11-24 | — | — | EP | disclosed |
| US-4346023-A | FLAVORS, PERFUMES | FIRMENICH SA (CH) | 1982-08-24 | — | — | US | disclosed |
| US-4302607-A | CYCLOPENTADECANONES | FIRMENICH SA (CH) | 1981-11-24 | — | — | US | disclosed |
| EP-0015412-A2 | Unsaturated macrocyclic ketones; their preparation; preparation of saturated macrocyclic ketones; application in perfume and flavour compositions of some unsaturated macrocyclic ketones | FIRMENICH SA (CH) | 1980-09-17 | — | — | EP | disclosed |